S2 Ep92: Beyond CRS and ICANS: Managing the Delayed Toxicities of Cilta-cel
Sara Scott, PharmD, BCOP, Emma Uchida, PharmD, MBA, BCOP, and Rebecca Gonzalez, PharmD, BCOP, gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.